Search
Investigating the disease- modifying properties of sclerotiorin in Alzheimer's therapy using acetylcholinesterase inhibition
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder caused due to the damage and loss of neurons in specific brain regions. It is the most common form of dementia observed in older people. The symptoms start with memory loss and gradually cause the inability to speak and do day-to-day activities. The cost of caring for those affected individuals is huge and is probably beyond most developing countries capability. Current pharmacotherapy for AD includes compounds that aim to increase neurotransmitters at nerve endings. This can be achieved by cholinergic neurotransmission through inhibition of the cholinesterase enzyme. The current research aims to find natural substances that can be used as drugs to treat AD. The present work identifies and explains compounds with considerable Acetylcholinesterase (AChE) inhibitory activities. The pigment was extracted from the Penicillium mallochii ARA1 (MT373688.1) strain using ethyl acetate, and the active compound was identified using chromatographic techniques followed by structural confirmation with NMR. AChE inhibition experiments, enzyme kinetics, and molecular dynamics simulation studies were done to explain the pharmacological and pharmacodynamic properties. We identified that the compound sclerotiorin in the pigment has AChE inhibitory activity. The compound is stable and can bind to the enzyme non-competitively. Sclerotiorin obeys all the drug-likeliness parameters and can be developed as a promising drug in treating AD.
Citations
-
0
CrossRef
-
0
Web of Science
-
0
Scopus
Authors (5)
-
Varun Thachan Kundil
-
Jayadevi Variyar E.
Cite as
Full text
full text is not available in portal
Keywords
Details
- Category:
- Articles
- Type:
- artykuły w czasopismach
- Published in:
-
Chemical Biology & Drug Design
no. 102,
pages 292 - 302,
ISSN: 1747-0277 - Language:
- English
- Publication year:
- 2023
- Bibliographic description:
- Ayyolath A., Kallingal A., Thachan Kundil V., Maniyeri Suresh A., E. J. V.: Investigating the disease- modifying properties of sclerotiorin in Alzheimer's therapy using acetylcholinesterase inhibition// Chemical Biology & Drug Design -Vol. 102,iss. 2 (2023), s.292-302
- DOI:
- Digital Object Identifier (open in new tab) 10.1111/cbdd.14244
- Sources of funding:
-
- Free publication
- Verified by:
- Gdańsk University of Technology
seen 86 times
Recommended for you
Glucosinolates from lepidium peruvianum as potential antiamnestic drugs
- D. Tarabasz,
- D. Szwajgier,
- P. Szczeblewski
- + 5 authors